Listings are for information only and do not constitute endorsements.
|Jump to:||Choose article section...FDA approves new Rx for overactive bladderSystem for soaking U/S probes won't take you to the cleaners Consumer-designed OC compact Chewable antibiotics for treating UTIs|
The Food and Drug Administration has approved Sanctura (Trospium chloride 20-mg tablets) for treating overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. Currently a leading prescription product for OAB and urinary incontinence in Europe, the tablets are now available in US pharmacies, according to Indevus Pharmaceuticals (Lexington, Mass.), who is co-promoting the product with PLIVA through its subsidiary, Odyssey Pharmaceuticals.
The agency's approval was based on a review of data from clinical studies on both continents involving some 3,000 subjects. The tablet was well tolerated, and its most commonly reported side effects in Phase III US trials were dry mouth and constipation. According to the company, it doesn't appear to cause metabolic drug-to-drug interactions. However, it is not for patients who have urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, or hypersensitivity to the pill.
For more information, visit the Web site http://www.sanctura.com.
The latest version of PCI Medical Inc.'s Compact Ductless Fume Systems for soaking delicate ultrasound probes can save big bucks when compared to conventional soaking methods that require ductwork, claims the manufacturer. Fumes from glutaraldehyde, orthophthalaldehyde (OPA), and other disinfectants are neutralized inside its patented carbon filter. Transvaginal and transrectal probes are suspended into the soak container of the G10VP or the G14KA stations to protect them during soaking. The systems, which come with two or three containers (one for rinsing) and include a locking safety door with two keys, meet OSHA and JCAHO safety requirements and are approved by leading U/S probe manufacturers. For a free demo video and pricing, contact PCI Medical at 1-800-862-3394 or visit http://www.pcimedical.com.
"Expressions" is the first consumer-designed birth control carrying case in Ortho-McNeil's Personal Pak line of discreet OC compacts. A panel led by fashion designer Nicole Miller chose the new design from entries in a company-sponsored contest for women last fall. According to Ortho-McNeil, the Ortho Personal Pak offers style and convenience to users of Ortho-Tri-Cyclen Lo (the only birth control pill with the combination of 25 µg ethinyl estradiol and norgestimate), making it highly effective despite a low level of hormones. Joining a collection that also includes eight existing designs, the com-pact can be ordered online at http://www.personalpak.com. For more information, visit these Web sites as well: http://www.orthotri-cyclenlo.com and http://www.orthowomenshealth.com.
The first chewable cephalosporin, Raniclor (cefaclor) is now available in 12-, 187-, 250-, and 375-mg strengths, according to Ranbaxy Pharmaceuticals Inc. (Jacksonville, Fla.). The chewable antibiotic features a twice- or three-times-daily dosing regimen and is indicated for treating bacterial infections like urinary tract infections, as well as otitis media, lower respiratory tract infections, and pharyngitis/tonsillitis. The product, which offers ease of dosing for patients who have difficulty swallowing tablets or capsules, has a fruity flavor and doesn't need to be refrigerated. (Ceclor is the branded version of cefaclor by Eli Lilly and Company that comes only in an oral suspension and capsule form.) For more information visit the company Web site: http://www.ranbaxyusa.com.
New Products. Contemporary Ob/Gyn Oct. 1, 2004;49:89.